Human Genetics
Disorders of the Nervous Tissue
Genomics
Neural Regulation
Genome-wide Association Studies-GWAS
Pharmacogenomics: Identification of New Drug Targets
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 26, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Guangchun Han1, Jiya Sun1, Jiajia Wang1
1CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Genomic technologies advance neurological disorder research by identifying new risk genes and biomarkers for conditions like Alzheimer's disease and autism spectrum disorder.
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: